Hello: You are invited to fill in the website's opinion survey form so that we can have more optimization and improvement directions and improve the user experience together.
Contact Us
CONTACT
TaiwanClinicalTrials.tw is an online information platform that is established and managed by the Center for Drug Evaluation (CDE) Taiwan to promote and to provide the essential information and excellence of Taiwan’s clinical trial environment to the public, academia and industry.
If you have any inquiry regarding clinical trial related events, information, and patient recruitments advertisement please fill out our inquiry form bellow.
If you need consultation services regarding regulations and clinical trial design please visit the consultation service page provided by CDE Taiwan.
Qualitix is one of lead CRO in Taiwan to provide full range of professional clinical services. Qualitix has been collaborated with pharmaceutical/biotech companies with new drug development in phase I-IV multinational clinical trials since 1997. In 2011, QPS acquired a majority interest in Qualitix from Genovate Biotechnology Co., Ltd. to form QPS-Qualitix. QPS-Qualitix now serves as a subsidiary of QPS Holdings, LLC in Asia to work with regional/global sponsors.
QPS, a GLP/GCP-compliant CRO that supports discovery, preclinical and clinical drug development, was founded by Dr. Benjamin M. Chien in 1995. QPS has posted impressive growth every year and has grown from a small molecule bioanalysis shop of three people to over 1150+ employees. QPS provides quality services in Neuropharmacology, DMPK, Toxicology, Bioanalysis, Translational Medicine, and Early & Late Phase Clinical Research to clients worldwide. QPS’s 30+ regional laboratories, clinical facilities and offices are located in North America, Europe, India and Asia.
During the past seven years, QPS-Qualitix conducted 580+ trials involving more than 50,000 subjects and 1,700 sites.
1.Experience in Divert Therapeutic Areas
Oncology
Dermatology
Infectious Diseases
Cardiovascular
Neurology
Pulmonology
Endocrinology
Hematology
Orthopedics
Medical Device/IVD kit
Ophthalmology
Psychiatry/Psychology
Immunology
Urology
Gastroenterology
Nephrology
Otolaryngology
Rheumatology
2.Experience from Phase I-IV
Phase
No. of Study
Site No.
Subject No.
I
250+
300+
6,800+
II
40+
140+
3,000+
III
110+
650+
6,000+
IV
70+
380+
19,000+
Others
100+
220+
15,000+
* “Others” includes observational studies, retrospective studies, listing studies, epidemiology studies, IIT studies, pilot studies, academic studies, IVD kit studies, medical device studies & insourcing service.
Services
01
Study Start-up: site selection, IRB/EC submission, clinical trial agreement preparation/negotiation
02
Clinical Trial Conduction: clinical project management, study site monitoring & management, safety reporting
03
Data Management (pCRF/eCRF) & Biostatistics
04
Medical Writing: study design, clinical study protocol/clinical study report development
05
Regulatory Inspection support: IRB audit support, TFDA inspection support
Global Accreditations
GOOD LABORTARY PRACTICE – STATE OF COMPLIANCE certification
